The pig as an optimal animal model for cardiovascular research
- PMID: 38773343
- DOI: 10.1038/s41684-024-01377-4
The pig as an optimal animal model for cardiovascular research
Abstract
Cardiovascular disease is a worldwide health problem and a leading cause of morbidity and mortality. Preclinical cardiovascular research using animals is needed to explore potential targets and therapeutic options. Compared with rodents, pigs have many advantages, with their anatomy, physiology, metabolism and immune system being more similar to humans. Here we present an overview of the available pig models for cardiovascular diseases, discuss their advantages over other models and propose the concept of standardized models to improve translation to the clinical setting and control research costs.
© 2024. Springer Nature America, Inc.
Similar articles
-
Tailored Pig Models for Preclinical Efficacy and Safety Testing of Targeted Therapies.Toxicol Pathol. 2016 Apr;44(3):346-57. doi: 10.1177/0192623315609688. Epub 2015 Oct 27. Toxicol Pathol. 2016. PMID: 26511847 Review.
-
Genetically modified pig models for human diseases.J Genet Genomics. 2013 Feb 20;40(2):67-73. doi: 10.1016/j.jgg.2012.07.014. Epub 2013 Jan 8. J Genet Genomics. 2013. PMID: 23439405 Review.
-
The pig as a model for immunology research.Cell Tissue Res. 2020 May;380(2):287-304. doi: 10.1007/s00441-020-03206-9. Epub 2020 Apr 30. Cell Tissue Res. 2020. PMID: 32356014 Free PMC article. Review.
-
Contribution of the swine model in the study of human sexually transmitted infections.Infect Genet Evol. 2018 Dec;66:346-360. doi: 10.1016/j.meegid.2017.11.022. Epub 2017 Nov 23. Infect Genet Evol. 2018. PMID: 29175001 Review.
-
The pig as a valuable model for testing the effect of resveratrol to prevent cardiovascular disease.Ann N Y Acad Sci. 2013 Jul;1290:130-5. doi: 10.1111/nyas.12216. Ann N Y Acad Sci. 2013. PMID: 23855475 Review.
References
-
- GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204–1222 (2020). - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources